immune based Applications
-
Proprietary Technologies for Approach Towards COVID-19
First generation COVID-19 vaccines generate a strong antibody response against SARS-CoV-2, the virus that causes COVID-19. These vaccines elicit neutralizing antibodies that can recognize the surface Spike protein of the virus and attack it before it infects cells. However, antibody responses may wane over time and long-term durability of protection remains unknown. Additionally, mutations in SARS-CoV-2 continuously arise, including in the Spike protein, and may further reduce clinical protection derived from ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Albumin focused biotechnology solutions for cell therapy sector
In cell therapy, the source and quality of albumin has proven important for both performance and regulatory purposes. Albumedix' recombinant human albumin products are used in a range of cell therapy media and products offering increased viability, consistency and ...
By Albumedix Ltd. based in Nottingham, UNITED KINGDOM.
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you